C of A [GxP / QC / QA]

posted by Ohlbe – France, 2011-02-10 17:01 (5605 d 15:06 ago) – Posting: # 6613
Views: 9,107

Dear VM,

CoA of what:
- of the investigational medicinal product administered to the subjects ? I would say yes. You want to be sure of what you give the subject. Not as important as in a BE (where you want to know the difference between T and R), but there is still an ethical concern.
- of the reference material you use in the lab to spike the standards and QCs ? This can be discussed more. On the one hand this is just a development study, so not regulated by guidelines. On the other hand you need some guarantee on whatever material you are going to use (You don't really care whether it is 99.9 or 99.8 % pure, but if it is just 80 %...). The answer depends on the source of the product and on the final goal of the study (what information do you want to get when giving only the reference product ?).

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
152 visitors (0 registered, 152 guests [including 16 identified bots]).
Forum time: 09:07 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5